Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Technologies Drive Hernia Repair Market

By HospiMedica International staff writers
Posted on 30 Sep 2010
Rapid adoption of biosynthetic mesh and other minimally invasive methods of hernia repair will increase revenues for manufacturers of hernia-repair specialty equipment. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent market research firm.

Biosynthetic mesh procedures provide benefits such as better a patient experience, greater resistance to infections and rapid tissue growth. These meshes, made up of silicone, rubber, polypropylene, or polytetrafluoroethylene (PTFE), create a protective layer that comes in contact with the intestine. Former developments include the laparoscopic repair method, widely adopted by 2000, which reduces invasiveness by patching hernias from the inside. Although once widely criticized for its high recurrence rate, continuing development of this procedure has led to a current near-zero rate of recurrence.

An important recent development is the perfection of the T-shaped prosthesis, composed of silicone and polypropylene, which reduces the development of incisional hernias, often caused by previous surgery. While the current average occurrence rate for incisional hernia cases is 15% - 20%, the use of T-shaped prosthesis is expected to reduce this figure to 3% - 4%. As a result, high-risk individuals with factors such as old age, previous surgery, obesity, and smoking, previously excluded from treatment, are expected to increase the number of hernia repair operations. In preparation, major industry players are preparing new products for this growing market.

"Biomesh and no-recurrence laparoscopy are not just small improvements, they are significant innovations,” said Bruce Carlson, the publisher of Kalorama Information. "There is a ton of innovation occurring in this market to meet the increasing demand for better quality.”

According to the Kalorama Information report, these new technologies will expand market sales to US$4.1 billion by 2012.

Related Links:
Kalorama Information


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.